Man Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
+10,843
| New | +$162K | ﹤0.01% | 1864 |
|
|
2022
Q4 | – | Sell |
-1,379
| Closed | -$18K | – | 2188 |
|
|
2022
Q3 | $18K | Buy |
+1,379
| New | +$18K | ﹤0.01% | 1899 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1969 |
|
|
2020
Q1 | – | Sell |
-1,648
| Closed | -$315K | – | 1838 |
|
|
2019
Q4 | $315K | Hold |
1,648
| – | – | ﹤0.01% | 1663 |
|
|
2019
Q3 | $317K | Sell |
1,648
-2,020
| -55% | -$389K | ﹤0.01% | 1646 |
|
|
2019
Q2 | $628K | Buy |
3,668
+64
| +2% | +$11K | ﹤0.01% | 1625 |
|
|
2019
Q1 | $725K | Sell |
3,604
-1,372
| -28% | -$276K | ﹤0.01% | 1643 |
|
|
2018
Q4 | $932K | Sell |
4,976
-7,001
| -58% | -$1.31M | ﹤0.01% | 1462 |
|
|
2018
Q3 | $2.87M | Sell |
11,977
-1,047
| -8% | -$251K | 0.01% | 1252 |
|
|
2018
Q2 | $3.45M | Buy |
+13,024
| New | +$3.45M | 0.01% | 1111 |
|